214 related articles for article (PubMed ID: 30851071)
1. Reduced lung cancer burden by selective immunomodulators elicits improvements in muscle proteolysis and strength in cachectic mice.
Salazar-Degracia A; Granado-Martínez P; Millán-Sánchez A; Tang J; Pons-Carreto A; Barreiro E
J Cell Physiol; 2019 Aug; 234(10):18041-18052. PubMed ID: 30851071
[TBL] [Abstract][Full Text] [Related]
2. Role of PARP activity in lung cancer-induced cachexia: Effects on muscle oxidative stress, proteolysis, anabolic markers, and phenotype.
Chacon-Cabrera A; Mateu-Jimenez M; Langohr K; Fermoselle C; García-Arumí E; Andreu AL; Yelamos J; Barreiro E
J Cell Physiol; 2017 Dec; 232(12):3744-3761. PubMed ID: 28177129
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological strategies in lung cancer-induced cachexia: effects on muscle proteolysis, autophagy, structure, and weakness.
Chacon-Cabrera A; Fermoselle C; Urtreger AJ; Mateu-Jimenez M; Diament MJ; de Kier Joffé ED; Sandri M; Barreiro E
J Cell Physiol; 2014 Nov; 229(11):1660-72. PubMed ID: 24615622
[TBL] [Abstract][Full Text] [Related]
4. Combined treatment of carfilzomib and z-VAD-fmk inhibits skeletal proteolysis and apoptosis and ameliorates cancer cachexia.
Wang Q; Li C; Peng X; Kang Q; Deng D; Zhang L; Zheng Y; Wang C; Qiao Z; Guo D; You S; Tang H
Med Oncol; 2015 Apr; 32(4):100. PubMed ID: 25737433
[TBL] [Abstract][Full Text] [Related]
5. Curcumin and Resveratrol Improve Muscle Function and Structure through Attenuation of Proteolytic Markers in Experimental Cancer-Induced Cachexia.
Penedo-Vázquez A; Duran X; Mateu J; López-Postigo A; Barreiro E
Molecules; 2021 Aug; 26(16):. PubMed ID: 34443492
[TBL] [Abstract][Full Text] [Related]
6. Prolonged Immobilization Exacerbates the Loss of Muscle Mass and Function Induced by Cancer-Associated Cachexia through Enhanced Proteolysis in Mice.
Mañas-García L; Penedo-Vázquez A; López-Postigo A; Deschrevel J; Durán X; Barreiro E
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33142912
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA expression and protein acetylation pattern in respiratory and limb muscles of Parp-1(-/-) and Parp-2(-/-) mice with lung cancer cachexia.
Chacon-Cabrera A; Fermoselle C; Salmela I; Yelamos J; Barreiro E
Biochim Biophys Acta; 2015 Dec; 1850(12):2530-43. PubMed ID: 26432600
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial dysfunction and therapeutic approaches in respiratory and limb muscles of cancer cachectic mice.
Fermoselle C; García-Arumí E; Puig-Vilanova E; Andreu AL; Urtreger AJ; de Kier Joffé ED; Tejedor A; Puente-Maestu L; Barreiro E
Exp Physiol; 2013 Sep; 98(9):1349-65. PubMed ID: 23625954
[TBL] [Abstract][Full Text] [Related]
9. Phenotypic and metabolic features of mouse diaphragm and gastrocnemius muscles in chronic lung carcinogenesis: influence of underlying emphysema.
Salazar-Degracia A; Blanco D; Vilà-Ubach M; de Biurrun G; de Solórzano CO; Montuenga LM; Barreiro E
J Transl Med; 2016 Aug; 14(1):244. PubMed ID: 27549759
[TBL] [Abstract][Full Text] [Related]
10. Effects of the beta
Salazar-Degracia A; Busquets S; Argilés JM; Bargalló-Gispert N; López-Soriano FJ; Barreiro E
Biochimie; 2018 Jun; 149():79-91. PubMed ID: 29654866
[TBL] [Abstract][Full Text] [Related]
11. Calpain inhibitors ameliorate muscle wasting in a cachectic mouse model bearing CT26 colorectal adenocarcinoma.
Lin XY; Chen SZ
Oncol Rep; 2017 Mar; 37(3):1601-1610. PubMed ID: 28112357
[TBL] [Abstract][Full Text] [Related]
12. A novel orthotopic mouse model replicates human lung cancer cachexia.
van de Worp WRPH; Theys J; González AS; van der Heyden B; Verhaegen F; Hauser D; Caiment F; Smeets HJM; Schols AMWJ; van Helvoort A; Langen RCJ
J Cachexia Sarcopenia Muscle; 2023 Jun; 14(3):1410-1423. PubMed ID: 37025071
[TBL] [Abstract][Full Text] [Related]
13. Antibody-directed myostatin inhibition enhances muscle mass and function in tumor-bearing mice.
Murphy KT; Chee A; Gleeson BG; Naim T; Swiderski K; Koopman R; Lynch GS
Am J Physiol Regul Integr Comp Physiol; 2011 Sep; 301(3):R716-26. PubMed ID: 21677277
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of attenuation of skeletal muscle protein catabolism in cancer cachexia by eicosapentaenoic acid.
Whitehouse AS; Smith HJ; Drake JL; Tisdale MJ
Cancer Res; 2001 May; 61(9):3604-9. PubMed ID: 11325828
[TBL] [Abstract][Full Text] [Related]
15. Activity level, apoptosis, and development of cachexia in Apc(Min/+) mice.
Baltgalvis KA; Berger FG; Peña MM; Mark Davis J; White JP; Carson JA
J Appl Physiol (1985); 2010 Oct; 109(4):1155-61. PubMed ID: 20651218
[TBL] [Abstract][Full Text] [Related]
16. Compound Z526 alleviates chemotherapy-induced cachectic muscle loss by ameliorating oxidative stress-driven protein metabolic imbalance and apoptosis.
Gu X; Lu S; Fan M; Xu S; Lin G; Zhao Y; Zhao W; Liu X; Dong X; Zhang X
Eur J Pharmacol; 2024 Jul; 974():176538. PubMed ID: 38552940
[TBL] [Abstract][Full Text] [Related]
17. Anticachectic effects of formoterol: a drug for potential treatment of muscle wasting.
Busquets S; Figueras MT; Fuster G; Almendro V; Moore-Carrasco R; Ametller E; Argilés JM; López-Soriano FJ
Cancer Res; 2004 Sep; 64(18):6725-31. PubMed ID: 15374990
[TBL] [Abstract][Full Text] [Related]
18. Nuclear transcription factor κ B activation and protein turnover adaptations in skeletal muscle of patients with progressive stages of lung cancer cachexia.
Op den Kamp CM; Langen RC; Snepvangers FJ; de Theije CC; Schellekens JM; Laugs F; Dingemans AM; Schols AM
Am J Clin Nutr; 2013 Sep; 98(3):738-48. PubMed ID: 23902785
[TBL] [Abstract][Full Text] [Related]
19. MG132-mediated inhibition of the ubiquitin-proteasome pathway ameliorates cancer cachexia.
Zhang L; Tang H; Kou Y; Li R; Zheng Y; Wang Q; Zhou X; Jin L
J Cancer Res Clin Oncol; 2013 Jul; 139(7):1105-15. PubMed ID: 23535871
[TBL] [Abstract][Full Text] [Related]
20. Luteolin reduces cancer‑induced skeletal and cardiac muscle atrophy in a Lewis lung cancer mouse model.
Chen T; Li B; Xu Y; Meng S; Wang Y; Jiang Y
Oncol Rep; 2018 Aug; 40(2):1129-1137. PubMed ID: 29845270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
